Literature DB >> 10682753

Immobilization of California sea lions using medetomidine plus ketamine with and without isoflurane and reversal with atipamezole.

M Haulena1, F M Gulland, D G Calkins, T R Spraker.   

Abstract

The use of medetomidine and ketamine, alone and in combination with isoflurane, with atipamezole reversal was evaluated for immobilizing 51 California sea lions (Zalophus californianus) for a variety of medical procedures at a rehabilitation center in northern California (USA) between May 1997 and August 1998. Animals were given 140 microg/kg medetomidine with 2.5 mg/kg ketamine intramuscularly. Mean (+/-SD) time to maximal effect was 8+/-5 min. At the end of the procedure, animals were given 200 microg/kg atipamezole intramuscularly. Immobilization and recovery times were, respectively, 25+/-12 and 9+/-7 min for 35 animals maintained with medetomidine and ketamine alone and 58+/-30 and 9+/-9 min for 16 animals intubated and maintained with isoflurane. No mortalities occurred as a result of the immobilizations. Disadvantages of the medetomidine and ketamine combination included a moderate variation in time to maximal effect and plane of sedation, a large injection volume and high cost. However, this combination offers safe and reversible immobilization that can be easily administered by the intramuscular route and that produces a plane of anesthesia that is sufficient to carry out most routine diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10682753     DOI: 10.7589/0090-3558-36.1.124

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  1 in total

1.  Determination of a sedative protocol for use in California sea lions (Zalophus californianus) with neurologic abnormalities undergoing electroencephalographic examination.

Authors:  Sophie Dennison; Martin Haulena; D Colette Williams; John Dawson; Brian S Yandell; Frances M D Gulland
Journal:  J Zoo Wildl Med       Date:  2008-12       Impact factor: 0.776

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.